{
  "query": "obesity",
  "resolved": null,
  "signals": [
    {
      "type": "hot_area",
      "headline": "\"obesity\" heating up — 0 grants ($0), 33 active trials (14 started <12 mo)",
      "entity": "obesity",
      "ticker": null,
      "upstream": {
        "event": "NIH grant velocity",
        "detail": "0 grants, $0 in window"
      },
      "observed": {
        "event": "Trial velocity",
        "detail": "33 trials, 14 newly started"
      },
      "predicted": {
        "event": "Elevated M&A / licensing / IPO activity in this mechanism over 12–24 mo",
        "leadTime": "12–24 mo",
        "note": "Funding+trial co-velocity historically precedes BD activity; directional only."
      },
      "leadTime": "12–24 mo to BD/commercial activity (directional)",
      "confidence": 0.5,
      "sponsors": [
        "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
        "Amgen",
        "University of Copenhagen",
        "University of Pittsburgh",
        "Arrowhead Pharmaceuticals",
        "AstraZeneca",
        "Beijing Anzhen Hospital",
        "National Heart, Lung, and Blood Institute (NHLBI)"
      ]
    }
  ],
  "recentFilings": null,
  "disclaimer": "Research/informational. NOT investment advice.",
  "generatedAt": "2026-11-03T09:00:20.748Z"
}